Neueste Versuche

EudraCT Number: 2006-001896-39 Sponsor Protocol Number: DUO 05 Start Date: 2006-12-07
Sponsor Name: SOFAR SPA
Full Title: Evaluation of symbiotic effect on the intestinal function in idiopathic chronic constipation. Multicenter, randomised, cross-over, double-blind, placebo-controlled study
Medical condition: CIdiopathic chronic constipation
Disease: Version SOC Term Classification Code Term Level
8.1 10010774 Constipation LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-001623-18 Sponsor Protocol Number: EGF102988 Start Date: 2006-12-07
Sponsor Name: GlaxoSmithKline Research & Development Limited
Full Title: A Randomised, Double-Blind, Placebo-Controlled, Multi-centre, Phase III Study of Post-Operative Adjuvant Lapatinib or Placebo and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib or P...
Medical condition: Resected Squamous Cell Carcinoma of the Head and Neck
Disease: Version SOC Term Classification Code Term Level
8.1 10041823 Squamous cell carcinoma LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FR (Completed) IE (Completed) GR (Completed) AT (Completed) SK (Completed) GB (Completed) DE (Completed) CZ (Completed) PT (Prematurely Ended) EE (Completed) HU (Completed) IT (Completed) LV (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2005-005654-53 Sponsor Protocol Number: BroSin 05 Start Date: 2006-12-07
Sponsor Name: Ursapharm Arzneimittel GmbH & Co. KG
Full Title: "Explorative triple-arm dosis-finding study for examination about the effectivity and tolerance of Bromelain by acute sinusitis"
Medical condition: Therapy of acute sinusitis
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2005-002438-37 Sponsor Protocol Number: 2005/VCC/0018(WCTU02) Start Date: 2006-12-07
Sponsor Name: Velindre NHS Trust
Full Title: A randomised phase III clinical trial investigating the effect of FRAGMin® Added to standard Therapy In patients with lung Cancer
Medical condition: Lung cancer
Disease: Version SOC Term Classification Code Term Level
14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10025044 Lung cancer LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2006-005626-24 Sponsor Protocol Number: 1247 Start Date: 2006-12-07
Sponsor Name: POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Full Title: PHASE II STUDY ON PEMETREXED IN ADVANCED AND/OR RECURRENT CERVICAL CANCER
Medical condition: advanced or metastatic cervical cancer
Disease: Version SOC Term Classification Code Term Level
6.1 10008342 PT
Population Age: Adults, Elderly Gender: Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2006-004398-89 Sponsor Protocol Number: 380104 Start Date: 2006-12-06
Sponsor Name: Medinova AG
Full Title: Comparative Study of the Efficacy of 10 mg Dequalinium Chloride (Fluomizin®) in the Local Treatment of Bacterial Vaginosis
Medical condition: Bacterial Vaginosis
Disease: Version SOC Term Classification Code Term Level
8.1 10004055 Bacterial vaginosis LLT
Population Age: Adults Gender: Female
Trial protocol: DE (Completed) AT (Prematurely Ended) CZ (Completed) SK (Completed)
Trial results: (No results available)
EudraCT Number: 2006-001846-15 Sponsor Protocol Number: CSUC-01/06 Start Date: 2006-12-06
Sponsor Name: InDex Pharmaceuticals AB
Full Title: A placebo-controlled, randomised, double-blind, single dose proof of concept study of Kappaproct, in steroid resistant or steroid dependent patients with ulcerative colitis of mild to moderate degree
Medical condition: Active ulcerative colitis in steroid refractory or steroid dependent patients
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2005-003901-10 Sponsor Protocol Number: 250317BS Start Date: 2006-12-06
Sponsor Name: Neosil Inc.
Full Title: A randomized, placebo controlled, double-blind study to evaluate the efficacy of topical formulations in male subjects with androgenetic alopecia
Medical condition: The study will be performed in male subjects with Norwood/Hamilton grades III - IV, androgenetic alopecia.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male
Trial protocol: DE (Completed)
Trial results: (No results available)
EudraCT Number: 2006-005082-19 Sponsor Protocol Number: RB23EZ Start Date: 2006-12-06
Sponsor Name: Research Innovation Services, University of Nottingham
Full Title: Effect of an angiotensin receptor antagonist on cerebral blood flow, cerebral perfusion pressure, and systemic and peripheral haemodynamics in patients with recent stroke.
Medical condition: Patients who have hypertension in the context of recent stroke.
Disease: Version SOC Term Classification Code Term Level
8.1 10015488 Essential hypertension LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2005-000474-42 Sponsor Protocol Number: CL2-90652-002 Start Date: 2006-12-06
Sponsor Name: INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
Full Title: Safety and effects on blood pressure of a daily dose of 0.025 to 0.135 milligram per kilogram of S 90652, a paediatric formulation of perindopril, in hypertensive children having received S 90652 -...
Medical condition: Arterial Hypertension
Disease: Version SOC Term Classification Code Term Level
14.1 10047065 - Vascular disorders 10015488 Essential hypertension PT
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren